Bioanalysis

Papers
(The TQCC of Bioanalysis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO41
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population30
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy29
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery26
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid25
Adopting ambient ionization mass spectrometry into bioanalytical laboratories22
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox21
Patient centric blood sampling and analysis for diagnostics and laboratory medicine18
The complexities of oligonucleotide therapeutics: analytical challenges and opportunities within early drug discovery16
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar14
MS-DIAL pre-processing for mining schistosomiasis metabolites in urine samples from the Okavango Delta of Botswana from a GC-MS dataset14
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics13
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations13
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis13
Selective IgM digestion improves anti-AAV IgG detection in the immune complex assay format12
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients12
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses12
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique11
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum11
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference11
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testing11
A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples11
Refined ADA testing strategy to overcome sRANKL interference in denosumab/FKS518 immunogenicity assessment11
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA10
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani10
Bioanalysis Rising Star Award 2024: interviews with the finalists10
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification9
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis9
Accelerating the discovery of MET inhibitors powered by high-throughput hit identification9
Significant matrix effect in fludarabine quantification in plasma: implications for CAR-T cell therapy monitoring9
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers9
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment9
Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies9
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma9
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS9
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers9
Development of a fit-for-purpose semi-homogeneous competitive ELISA for total PEG quantitation in a PEGylated molecule9
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS8
Determination of meropenem in capillary plasma microsamples using LC–MS/MS8
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System8
Correction8
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma8
Highlights of the 15th Japan Bioanalysis Forum Symposium8
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled8
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider8
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency8
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers8
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements8
Highlights of the 13th Japan Bioanalysis Forum Symposium8
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS7
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers7
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients7
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing7
Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS)7
Validation of UV–Vis spectrophotometric colorimetric methods for Rifampicin quantification in PBS & biological matrices7
Nucleic acid nanorobot assay for accurate and simplified ASO quantification in mouse plasma7
An interview with Bioanalysis : speaking with the 2025 international reid bioanalytical forum bursary award winners6
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum6
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond6
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions6
Rethinking validation paradigms for qPCR and dPCR assays in bioanalysis6
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays6
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study6
Beyond contracts: principles for Pharma–CRO collaboration from the European Bioanalysis Forum6
Greener Bioanalytical Sample Preparation. What is Next?6
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin6
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry6
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe6
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications6
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis6
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting6
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats5
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens5
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development5
When is a sample a urine sample? Markers for urine sample authenticity assessment in sports drug testing5
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study5
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery5
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates5
Detection of Streptococcus anginosus in fecal samples using PCR-CRISPR /Cas12a system5
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling5
LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies5
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten5
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma5
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis5
The acute oral toxicity and pharmacokinetic determination of a novel chloroquinoline hybrid molecule by LC-MS/MS5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS5
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides4
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment4
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps4
Thyroxine Biosensors: A Review on Progress and Challenges4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine4
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control4
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy4
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies4
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis4
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development4
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu4
High-resolution mass spectrometry for glycoproteomics4
Development and validation of highly sensitive ligand binding assay to measure soluble DLL3 concentration in human serum4
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints4
Bioanalytical tandem mass spectrometry method for cinacalcet in human plasma: green assessment with advanced metrics4
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications4
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management4
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid4
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents4
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats4
Harmonization of Vaccine Ligand Binding Assays Validation4
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective4
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV4
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform4
Integrating metering capabilities to increase the utility of self-collected, dried samples3
Effect of delayed blood centrifugation on cytokine quantitation in serum and plasma3
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies3
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?3
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; 3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats3
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk3
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay3
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum3
Research progress of N -nitrosamine detection methods: a review3
Analytical Considerations to Support Expeditious Formulation Development of Vaccines3
A Bioanalytical Screening Method for Enterococcus faecalis RNPP-type Quorum Sensing Peptides in Murine Feces3
Development of a UPLC-MS/MS method for simultaneous quantification of 7 bile acids in feces: application to UC mice3
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency3
Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease3
Large Molecule Bioanalysis by LC–MS: Beyond Simply Quantifying3
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay3
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?3
China's NMPA Perspective on the Clinical Performance of SARS-CoV-2 Antigen Test Reagents3
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment3
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring3
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis3
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population3
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis3
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories3
High-Throughput MS for Intact Protein Analysis3
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum3
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum3
LC-MS/MS Methods to quantify HCP002 in Human Plasma and Urine: Applications in a Pharmacokinetic Study3
Bioanalysis Rising Star Award 2023: announcing our finalists3
Comparison of Liquid–Liquid Extraction, Microextraction and Ultrafiltration for Measuring Free Concentrations of Testosterone and Phenytoin3
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio3
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline3
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective3
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood3
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts3
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena3
Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites3
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover3
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics3
Method development and validation for simultaneous analysis of four bile acids as CYP3A drug–drug interaction biomarkers3
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography3
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS3
Simultaneous quantitation of tigecycline, meropenem, polymyxin B in plasma, and protein-binding analysis in HSCT patients3
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study3
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes3
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode3
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS3
0.10349011421204